Centurykang Announces Launch of Its Self-Developed Second-Generation Aspheric Scleral Lens

Aug 23, 2024 17:55 CST Updated 17:55

Century Healthcare

Medical Device Manufacturer, R&D, and Distributor

Click to follow? | Focused on Global Biomedical Investment

On August 22, Century Healthcare announced more good news: its independently developed second-generation aspherical scleral lens—Meishi Ji® Rigid Scleral Contact Lens—officially received the Class III medical device registration certificate issued by the National Medical Products Administration.Registration Certificate No. GJXZZ 20243161538.Century Healthcare has been approved for 9 Class III medical device registration certificates. EdgeFocus Capital participated in the investment in Century Healthcare in 2023.

Meishi Season® Rigid Scleral Contact Lens is the 2nd generation non-spherical scleral lens. Like other high-end ophthalmic products from Century Healthcare, it features several innovative technologies that are firsts in China:

China's first "2nd Generation Aspheric" design:The newly upgraded scleral lens optic zone achieves aspheric design tailored to different patients, allowing each patient to achieve optimal visual quality; utilizing the proprietary patented "phase modulation technology" (Patent No. 202210500567X) to correct whole-eye wavefront aberrations, restoring youthful and excellent visual quality with high-definition vision.

China's First Truly Four-Zone Independent Scleral Lens: Precisely matches various corneoscleral shapes, easy to fit, comfortable to wear;

Another:
1）Bitoric Design:Accurately address asymmetric scleral morphology, ensure lens stability, and guarantee precise astigmatism correction.
2）Landing Zone Tangent Design:Achieves the optimal balance between scleral lens tear exchange and stable wear;
3）360° Coaxial Tangential Design:Can better control the light path and reduce visual distortion.

Numerous user-friendly designs can better meet the personalized needs of thousands of people. The brilliant debut of the 2nd generation aspheric scleral lens has expanded the company's product pipeline and further broadened the range of patients served by the products.

About Century Healthcare

Century Healthcare is a Class III high-end medical device manufacturing enterprise that integrates research and development, production, and sales. Relying on excellent scientific research platforms and guided by the strategic direction of an "innovative ophthalmic materials and optical design platform," Century Healthcare covers areas such as intraocular lenses, optometry, and biomaterials like collagen. It currently has more than 20 products applied in ophthalmology, surgery, and medical aesthetics.

The company has obtained more than 80 invention and utility model patents, with 8 Class III medical device registration certificates and 3 Class II medical device registration certificates approved by the National Medical Products Administration. In addition, the company's intraocular lens products have also obtained foreign certifications such as CE certification.

In 2023, Century Healthcare's multi-focal and extended depth-of-field intraocular lenses, scleral lenses, and orthokeratology lenses have all completed clinical enrollment. The company has become an "innovative ophthalmic materials and optical technology platform enterprise" with a presence in the fields of cataract refractive surgery, optometry, and biomaterials such as collagen.

It is currently one of the few enterprises in China's ophthalmology field that simultaneously masters core technologies such as the optical design, processing, and production of hydrophilic, hydrophobic, monofocal, and multifocal intraocular lenses. Among these, the "-0.1μm spherical aberration design," "edge-enhanced zero spherical aberration," "hollow haptics," and "625 large optical zone" are all domestic firsts for aspheric intraocular lenses in China. Moreover, its collagen sponge product was granted the first Class III medical device registration certificate for full surgical use by the National Medical Products Administration under the new standards since 2011.